GlassScriptFilmarray Pneumonia Panel (Pneumo)
Payments companies reported to CMS as associated with Filmarray Pneumonia Panel (Pneumo). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Filmarray Pneumonia Panel (Pneumo), per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Filmarray Pneumonia Panel (Pneumo)
These are the largest totals companies reported as associated with Filmarray Pneumonia Panel (Pneumo). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Tufik Assad | Boston, MA | Pulmonary Disease | $25,064.30 |
| Trevor Vanschooneveld | Omaha, NE | Infectious Disease | $12,901.53 |
| Nicole Haig | East Point, GA | Emergency Medicine | $12,335.96 |
| Devendra Amin | Clearwater, FL | Pulmonary Disease | $8,865.85 |
| Arthur Jeng | Sylmar, CA | Infectious Disease | $8,714.72 |
| Owen Albin | Ann Arbor, MI | Infectious Disease | $7,708.62 |
| Bradley Connor | New York, NY | Gastroenterology (Internal Medicine) | $7,539.00 |
| Zoe Weiss | Boston, MA | Infectious Disease | $5,616.90 |
| Ferric Fang | Seattle, WA | Infectious Disease | $5,166.00 |
| Daniel Feinstein | Pinehurst, NC | Critical Care Medicine (Internal Medicine) | $3,657.54 |
Prescribed Filmarray Pneumonia Panel (Pneumo)?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.